EP1546734 - N-11 TRUNCATED AMYLOID-BETA MONOCLONAL ANTIBODIES, COMPOSITIONS, METHODS AND USES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.09.2016 Database last updated on 06.11.2024 | Most recent event Tooltip | 16.09.2016 | No opposition filed within time limit | published on 19.10.2016 [2016/42] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [2015/46] |
Former [2005/26] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutseweg 30 2340 Beerse / BE | Inventor(s) | 01 /
MERCKEN, Marc, Hubert Janssen Pharmaceutica N.V. Turnhoutseweg 30 2340 Beerse / BE | 02 /
VANDERMEEREN, Marc, Maria, Pierre, Pelagie Janssen Pharmaceutica N.V. Turnhoutseweg 30 2340 Beerse / BE | [2015/46] |
Former [2005/26] | 01 /
MERCKEN, Marc Hubert, Janssen Pharmaceutica N.V. Turnhoutseweg 30 2340 Beerse / BE | ||
02 /
VANDERMEEREN, Marc M.P.P, Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | Application number, filing date | 03798156.0 | 09.09.2003 | [2005/26] | WO2003EP10092 | Priority number, date | WO2002EP11062 | 27.09.2002 Original published format: PCT/EP0211/062 | [2005/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004029630 | Date: | 08.04.2004 | Language: | EN | [2004/15] | Type: | A1 Application with search report | No.: | EP1546734 | Date: | 29.06.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.04.2004 takes the place of the publication of the European patent application. | [2005/26] | Type: | B1 Patent specification | No.: | EP1546734 | Date: | 11.11.2015 | Language: | EN | [2015/46] | Search report(s) | International search report - published on: | EP | 08.04.2004 | Classification | IPC: | G01N33/68, C12N5/20, C07K16/18 | [2005/26] | CPC: |
G01N33/6896 (EP,US);
A61P25/28 (EP);
A61P9/00 (EP);
C07K16/18 (EP,US);
C07K2317/34 (US);
G01N2333/4709 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2015/46] |
Former [2005/26] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR | Extension states | AL | 27.04.2005 | LT | 27.04.2005 | LV | 27.04.2005 | MK | 27.04.2005 | Title | German: | MONOKLONALE ANTIKÖRPER GEGEN IN N-11 VERKÜRZTES BETA-AMYLOID, ZUSAMMENSETZUNGEN,VERFAHREN UND VERWENDUNGEN | [2015/26] | English: | N-11 TRUNCATED AMYLOID-BETA MONOCLONAL ANTIBODIES, COMPOSITIONS, METHODS AND USES | [2005/26] | French: | ANTICORPS MONOCLONAUX TRONQUES RECONNAISSANT LES PEPTIDES BETA-AMYLOIDES N-11, COMPOSITIONS, PROCEDES ET APPLICATIONS | [2005/26] |
Former [2005/26] | MONOKONOALE ANTIKÖRPER GEGEN IN N-11 VERKÜRZTES BETA-AMYLOID, ZUSAMMENSETZUNGEN,VERFAHREN UND VERWENDUNGEN | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 27.04.2005 | National basic fee paid | 27.04.2005 | Designation fee(s) paid | 27.04.2005 | Examination fee paid | Examination procedure | 25.03.2004 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 27.04.2005 | Examination requested [2005/26] | 26.02.2007 | Despatch of a communication from the examining division (Time limit: M06) | 27.08.2007 | Reply to a communication from the examining division | 18.05.2009 | Despatch of a communication from the examining division (Time limit: M06) | 23.10.2009 | Reply to a communication from the examining division | 13.04.2011 | Despatch of a communication from the examining division (Time limit: M06) | 24.10.2011 | Reply to a communication from the examining division | 19.06.2013 | Despatch of a communication from the examining division (Time limit: M04) | 03.10.2013 | Reply to a communication from the examining division | 30.04.2015 | Cancellation of oral proceeding that was planned for 19.05.2015 | 19.05.2015 | Date of oral proceedings (cancelled) | 29.05.2015 | Communication of intention to grant the patent | 11.09.2015 | Fee for grant paid | 11.09.2015 | Fee for publishing/printing paid | 11.09.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.02.2007 | Opposition(s) | 12.08.2016 | No opposition filed within time limit [2016/42] | Fees paid | Renewal fee | 30.09.2005 | Renewal fee patent year 03 | 02.10.2006 | Renewal fee patent year 04 | 01.10.2007 | Renewal fee patent year 05 | 31.03.2008 | Renewal fee patent year 06 | 30.09.2009 | Renewal fee patent year 07 | 30.09.2010 | Renewal fee patent year 08 | 30.09.2011 | Renewal fee patent year 09 | 01.10.2012 | Renewal fee patent year 10 | 30.09.2013 | Renewal fee patent year 11 | 30.09.2014 | Renewal fee patent year 12 | 30.09.2015 | Renewal fee patent year 13 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO0162801 (UNIV WASHINGTON [US], et al) [A] 1-16 * the whole document * | [X] - SAITO TAKANOMI C ET AL, "Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.", NEUROSCIENCE LETTERS, (1996), vol. 215, no. 3, ISSN 0304-3940, pages 173 - 176, XP002236342 [X] 1-16 * page 173 * DOI: http://dx.doi.org/10.1016/0304-3940(96)12970-0 | [DA] - NASLUND JAN ET AL, "Relative abundance of Alzheimer A-beta amyloid peptide variants in Alzheimer disease and normal aging.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, 1994, (1994), vol. 91, no. 18, ISSN 0027-8424, pages 8378 - 8382, XP002236343 [DA] 1-16 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.91.18.8378 | [A] - VASSAR R ET AL, "BETA-SECRETASE CLEAVAGE OF ALZHEIMER'S AMYLOID PRECURSOR PROTEIN BYTHE TRANSMEMBRANE ASPARTIC PROTEASE BACE", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, (1999), vol. 286, no. 5440, ISSN 0036-8075, pages 735 - 741, XP000914811 [A] 1-16 * the whole document * DOI: http://dx.doi.org/10.1126/science.286.5440.735 | Examination | - ASAMI-ODAKA A ET AL, "Long amyloid Beta-protein secreted from wild-type human neurblastoma IMR-32 cells", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19950101), vol. 34, no. 32, doi:10.1021/BI00032A022, ISSN 0006-2960, pages 10272 - 10278, XP002973741 DOI: http://dx.doi.org/10.1021/bi00032a022 | - MORT J S ET AL, "The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways", MP. MOLECULAR PATHOLOGY, BMJ PUBLISHING GROUP, LONDON, GB, (19990201), vol. 52, no. 1, ISSN 1366-8714, pages 11 - 18, XP002670376 DOI: http://dx.doi.org/10.1136/mp.52.1.11 | - IDA ET AL, "Analysis of heterogeneous ssA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, (19960913), vol. 271, no. 37, doi:10.1074/JBC.271.37.22908, ISSN 0021-9258, pages 22908 - 22914, XP002138701 DOI: http://dx.doi.org/10.1074/jbc.271.37.22908 |